+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Vascular Embolization Market Overview:
Global Vascular Embolization Market Size was valued at USD 1.6 Billion in 2022. The Vascular Embolization marketEmbolization Technique is projected to grow from USD 1.8 Billion in 2023 to USD 4.3 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.30% during the forecast period (2023 - 2032). Vascular diseases are growing increasingly prevalent, and technological advancements in embolization products and processes, are the key market drivers enhancing the market growth.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
The main drivers of the worldwide vascular embolization market are technological developments in embolization products and techniques, increased R&D activities, and the growth in demand for minimally invasive procedures. In recent years, patients' tastes for treating a variety of disorders have changed to favor minimally intrusive treatments. Additionally, it is safer because the recovery period is less than with traditional open operations. Another less invasive method for stopping blood supply to abnormal tissue masses is vascular embolization. Patients' increasing attitudes toward less invasive vascular embolization are driving the market's expansion. The desire for minimally invasive procedures is expected to enhance market growth for vascular embolization.
The enhanced efficacy of embolization plugs in minimally invasive vascular occlusion treatments, together with other technological advancements in this area, are also projected to fuel market growth. However, vascular embolization's high price and associated issues restrict market expansion. As cases of hepatocellular carcinoma and liver cancer rise, embolotherapy will likewise become more common. During the anticipated term, opportunities will be generated as a result of the unrealized potential in rising economies and the expanding healthcare infrastructure. In addition, governments around the world are investing significantly in enhancing healthcare infrastructure, and the medical tourism industry is expanding quickly in emerging economies. These factors together contribute to the rise in demand for advanced healthcare services. The booming healthcare industry in emerging economies is a result of all of these reasons. As a result, it is projected that all of these factors will offer the industry room to expand.
Over the course of the predicted period, it is anticipated that the global market for vascular embolization will expand as vascular disorders grow more common. Vascular disease is the term used to describe any condition that affects the blood vessel network. They are common and might be harmful. For instance, according to the World Health Organization (WHO), 17.9 million people worldwide die from cardiovascular diseases (CVDs), making them the leading cause of death. 35 percent of all deaths globally are caused by this. During the projection period, advancements in embolization instruments and procedures should accelerate market growth. For instance, Terumo Medical Corporation stated that its AZUR Vascular Plug would be available starting in July 2021. It is the first and only plug that can occlude arteries using a micro-catheter with a diameter of up to 8 mm. It is advised to use the most recent addition to Terumo's wide range of embolization techniques to reduce or halt blood flow via the arteries in the peripheral vasculature.Thus, driving the Vascular Embolization market revenue.
The global Vascular Embolization market segmentation, based on Application, includes peripheral vascular disease, oncology, neurology, urology, and other applications. Neurology segment dominated the global Vascular Embolization market in 2022.An increase in brain aneurysms is to blame for this. But due to an increase in cancer patients, oncology is predicted to have the highest CAGR during the forecast period.
The global Vascular Embolization market segmentation,based on Embolization Technique, includes coiling devices and non-coiling devices.Non-coiling devicessegment dominated the global market in 2022. The category is expected to increase due to a number of variables, such as the growing number of target patients and the burden of chronic diseases. According to the World Health Organization report 2020, heart disease is the leading cause of death globally. As a result of the development in chronic diseases, the mortality rate has been rising over the past 20 years. Since 2000, there have been approximately 2 million extra heart-related deaths, increasing the total to around 9 million in 2019. In the US, heart disease currently accounts for 16% of all fatalities. This shows that there might be some market demand for vascular embolization. As a result of the increasing burden of various chronic conditions, further growth of the studied market is projected.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
By region, Insights into the markets in North America, Europe, Asia-Pacific, and the rest of the world are provided by the study.The North America Vascular Embolization Market dominated this market in 2022 (45.80%). This is a result of growing research and development efforts as well as the rising frequency of vascular and cancer-related disorders in this region. According to the American Cancer Society, there will be around 89,500 newly diagnosed cases of cancer among adolescents and young adults (AYAs) between the ages of 15 and 39, and there will be about 9,270 cancer fatalities nationwide in 2020. Embolization is one of the most often used cancer therapeutic choices for patients with a variety of clinical conditions. The intention is to induce tumor ischemia, which will result in tumor necrosis.Further, In the North American area, the U.S. Vascular Embolization market had the biggest market share, while the Canada Vascular Embolization market had the quickest rate of expansion.
Further, the major countries studiedin the market reportare The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
EuropeVascular Embolization marketaccounted for the healthy market share in 2022.This is a result of the expansion of research and development efforts in this field as well as the increased frequency of vascular and cancer-related disorders. Further, In the European region, the German Vascular Embolization market had the biggest market share, and the U.K. Vascular Embolization market had the quickest rate of growth.
The Asia Pacific Vascular Embolization market is expected to register significant growth from 2023 to 2032. This is brought on by the region's growing population, altered lifestyles, and increased knowledge of vascular embolization.Moreover, In the Asia-Pacific region, the Indian Vascular Embolization market had the quickest rate of growth while China's Vascular Embolization market had the greatest market share.
Leading industry companies are making significant R&D investments in order to diversify their product offerings, which will drive the Vascular Embolization market's expansion. Important market developments include new product releases, contractual agreements, mergers and acquisitions, greater investments, and collaboration with other organizations. Market participants are also engaging in a number of strategic actions to increase their global footprint. The Vascular Embolization sector needs to provide affordable products if it wants to grow and thrive in a more competitive and challenging market environment.
One of the primary business strategies employed by manufacturers in the worldwide Aerospace Foam industry to assist customers and expand the market sector is local manufacturing to reduce operational costs. Some of the biggest benefits to medicine have recently come from the Vascular Embolization sector. Major players in the Vascular Embolization market, including Shape Memory Medical Inc., Terumo Corp, Abbott Laboratories, Stryker Corporation, Cook Medical, Medtronic PLC, Merit Medical Systems Inc., Penumbra Inc., Johnson and Johnson (Cerenovus), and Boston Scientific Corporation, are attempting to increase market demand by investing in research and development operations.
Terumo Corp. (Terumo) manufactures and sells equipment as well as hospital and medical supplies. Some of its primary product categories include pharmaceuticals, blood bags, disposable medical equipment, dietary supplements, cardiovascular systems, vascular grafts, blood glucose monitoring systems, medical electronics, peritoneal dialysis, and digital thermometers. The company's solutions are employed in therapies performed inside blood arteries as well as cardiac and vascular surgery. Terumo also manages blood banks that gather and prepare blood to satisfy patient transfusion requirements. Through subsidiaries and affiliates spread out across the Middle East, Africa, Europe, North America, South America, Asia Pacific, Japan, and China, the company conducts business. Terumo's corporate headquarters are in Tokyo. In July 2021, Terumo Medical Corporation (TMC) will make the AZUR Vascular Plug, the first and only plug able to occlude arteries up to 8mm in diameter, available. The most recent development in Terumo's broad embolization product line is designed to be used to reduce or stop blood flow in peripheral vascular arteries.
Stryker Corp (Stryker), a pioneer in medical technology, is a manufacturer of a range of orthopedic, medical, surgical, neurotechnology, and spine apparatus as well as associated services. Orthopedic implants, surgical tools and navigation systems, patient handling equipment, disposable intensive care supplies, and endoscopic and communication systems are among the company's primary products. Additionally, it provides spinal devices, neurosurgical equipment, and medical equipment for use in a variety of illnesses. Stryker sells items to physicians, hospitals, and other medical facilities. The corporation distributes its goods through subsidiaries, branches, independent dealers, and distributors in the Americas, Europe, Asia-Pacific, the Middle East, and Africa. The Stryker corporate office is located in Kalamazoo, Michigan, in the United States. In November 2020, Stryker purchased Wright Medical, a worldwide company that produces medical equipment and has a focus on biologics and extremities.
· Shape Memory Medical Inc.
· Terumo Corp
· Abbott Laboratories
· Stryker Corporation
· Cook Medical
· Medtronic PLC
· Merit Medical Systems Inc.
· Penumbra Inc.
· Johnson and Johnson (Cerenovus)
· Boston Scientific Corporation
February 2021: In the United States and Canada, Cook Medical released Approach Authority 0.018 diameter Workhorse Microwire Guide to help with the installation of balloon dilation catheters during percutaneous transluminal angioplasty. This device performs a variety of tasks simultaneously.
August 2020:Stryker announced the release of the Surpass Evolve flow diverter after getting US approval for the device, which is recommended for brain aneurysms.
April 2021:The US Food and Drug Administration (FDA) has approved the Pipeline Flex Embolization Device with Shield Technology of Medtronic PLC, which was principally recommended for brain aneurysms. Shield Technology lessens the material's thrombogenicity, which enhances the flow diverter device.
· Coiling Devices
· Non-coiling Devices
· Peripheral Vascular Disease
· Oncology
· Neurology
· Urology
· Other Applications
· North America
- US
- Canada
· Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
· Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
· Rest of the World
- Middle East
- Africa
- Latin America
Report Scope
|
Report Attribute/Metric |
Details |
|
Market Size 2022 |
USD 1.6 Billion |
|
Market Size 2023 |
USD 1.8 Billion |
|
Market Size 2032 |
USD 4.3 Billion |
|
Compound Annual Growth Rate (CAGR) |
10.30% (2023-2032) |
|
Base Year |
2022 |
|
Market Forecast Period |
2023-2032 |
|
Historical Data |
2018- 2022 |
|
Market Forecast Units |
Value (USD Billion) |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
Embolization Technique, Application, and Region |
|
Geographies Covered |
North America, Europe, AsiaPacific, and the Rest of the World |
|
Countries Covered |
The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
|
Key Companies Profiled |
Shape Memory Medical Inc., Terumo Corp, Abbott Laboratories, Stryker Corporation, Cook Medical, Medtronic PLC, Merit Medical Systems Inc., Penumbra Inc., Johnson and Johnson (Cerenovus), and Boston Scientific Corporation |
|
Key Market Opportunities |
Surge in technological innovation |
|
Key Market Dynamics |
Increasing prevalence of vascular diseases and technological advancements in embolization products and procedures |
The global Vascular Embolization Market was valued at USD 1.6 billion in 2022, and it is estimated to reach USD 4.3 billion by 2032.
The global market is projected to grow at a CAGR of 10.30% during the forecast period, 2023-2032.
North Americahad the largest share in the global market
The key players in the market are Shape Memory Medical Inc., Terumo Corp, Abbott Laboratories, Stryker Corporation, Cook Medical, Medtronic PLC, Merit Medical Systems Inc., Penumbra Inc., Johnson and Johnson (Cerenovus), and Boston Scientific Corporation
The Non-coiling DevicesEmbolization Techniquedominated the market in 2022.
The NeurologyApplicationhad the largest share in the global market.
Report Code :
RL6584
Published on :
Aug 2023
Request a Free Sample Report
Speak to Analyst